.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

TECHNESCAN MAG3 Drug Profile

« Back to Dashboard
Technescan Mag3 is a drug marketed by Mallinkrodt Nuclear and is included in one NDA. It is available from two suppliers.

The generic ingredient in TECHNESCAN MAG3 is technetium tc-99m mertiatide kit. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the technetium tc-99m mertiatide kit profile page.

Summary for Tradename: TECHNESCAN MAG3

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2

Clinical Trials for: TECHNESCAN MAG3

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinkrodt Nuclear
TECHNESCAN MAG3
technetium tc-99m mertiatide kit
INJECTABLE;INJECTION019882-001Jun 15, 1990RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TECHNESCAN MAG3

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mallinkrodt Nuclear
TECHNESCAN MAG3
technetium tc-99m mertiatide kit
INJECTABLE;INJECTION019882-001Jun 15, 19905,573,748<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc